Long Term COVID-19 Vaccine Data: Sustained Vascular Injury and Thrombosis at 2 Years

Li, JX., Wang, YH., Bair, H. et al. Risk assessment of retinal vascular occlusion after COVID-19 vaccination. npj Vaccines 8, 64 (2023). https://doi.org/10.1038/s41541-023-00661-7By Peter A. McCullough, MD, MPH

Early in 2020 I published with former US FDA physician Dr. Zhang that the SARS-CoV-2 viral Spike protein was damaging the vascular endothelium and causing blood clotting. This means capillaries would be systemically injured if exposed high concentrations of the Spike protein. Dr. Bruce Patterson has demonstrated the Spike protein is long-lasting (months to years) in the human body after both severe COVID-19 infection and vaccination. This leads us to a concern, that the vaccinated would have sustained vascular damage over the long-term. Now the first two-year data report in and the news could not be worse. The serious implications for long term cardiovascular risk cannot be understated.Xi et al used the massive TriNetX network with data on 95,156,967 individuals, of whom 7,318,437 met the inclusion criteria. After excluding cases with COVID-19 illness, 6,755,737 individuals were separated into two cohorts: 883,177 vaccinated and 5,871,737 unvaccinated individuals. In both cohorts, any diagnosis of retinal vascular occlusion six months and treatments including antiplatelets, anticoagulants, diuretics, contraceptives, used 4 weeks prior to the index date. Ultimately, 745,041 vaccinated and 3,874,458 unvaccinated individuals yielding matched pairs of 739,066 vaccinated cohorts to the unvaccinated cohort at a ratio of 1:1.

The results are striking. There is a progressively increasing risk of both arterial and venous occlusion in the retina over two years after injection and the survival curves continue to separate. The source the thrombi can be from the heart, aorta, carotids, and ultimately the blood vessels servicing the eyes and returning venous blood from the eye in the ocular orbit. The eye is a window to the systemic vasculature. In aggregate, these data drive the compelling conclusion that mass vaccination has caused ongoing, cumulative vascular injury in some recipients that has continued for at least two years. These data predict a rise in nonfatal and fatal events associated with progressive atherosclerotic cardiovascular disease including: 1) myocardial infarction (heart attack), 2) stroke 3) peripheral vascular disease with systemic embolism, 4) critical limb ischemia with amputation. Additionally, vaccine recipients are likely to be generally hypercoagulable and are set up for venous thromboembolism with usual provocateurs (surgery, prolonged immobility, estrogen use, etc.).

The practical ramifications are many: 1) like patients with diabetes mellitus recipients should be vigilant and have a low threshold to see an ophthalmologist for a dilated retinal exam if there are any visual symptoms, 2) medical doctors and their patients should be assiduous in the detection and treatment of atherothrombotic disease in the coronary and systemic vasculature, 3) The National Eye Institute, American Association of Ophthalmology, National Heart Lung and Blood Institute, American Heart Association, American College of Cardiology, American Neurological Association, and all physician and hospital stakeholders should join me in calling for an immediate moratorium on COVID-19 vaccination.

See also

IZhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med. 2020 Sep 30;21(3):315-319. doi: 10.31083/j.rcm.2020.03.126. PMID: 33070537.

Dr. McCullough US Senate: to Save Lives Pull the COVID-19 Vaccines off the Market, Dec 7, 2022

Via https://petermcculloughmd.substack.com/p/long-term-covid-19-vaccine-data-evidence/